CIK 0001783328 · <br>Emerging growth company
TScan Therapeutics, Inc.
Sign in to watch- Ticker
- TCRX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 825282075
- Phone
- 857-399-9500
- Business address
- 830 WINTER STREET, WALTHAM, MA, 02451
- SC 13G Stake Amended Statement of Ownership
- SC 13D/A Stake Beneficial Ownership Report
- DEFA14A Proxy Proxy Materials
- 4 Insider Changes in Ownership
- 8-K Event Material agreement · Other events
- 8-K Event Executive or director change · Regulation FD disclosure
- 424B5 Offering Prospectus
- FWP Offering Free Writing Prospectus
- 424B5 Offering Prospectus
- 8-K Event Other events
- EFFECT Other Notice of Effectiveness
- EFFECT Other Notice of Effectiveness
- 8-K Event Other events
- 424B5 Offering Prospectus
- AW Other AW
- S-3/A Offering Registration Statement
- S-3/A Offering Registration Statement
- S-3/A Offering Registration Statement
- CORRESP Other Correspondence Between Filers and SEC Staff
- CORRESP Other Correspondence Between Filers and SEC Staff
Page 10 of 17 · 336 filings